Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

Brain interference explains why multitasking becomes difficult

10

Sep 2026

Brain interference explains why multitasking becomes difficult

Multitasking feels like a required skill in modern life, but as anyone who has tried keeping track of multiple chat windows, an email inbox, and a stream of phone notifications during a video call can tell you, figuring out which messages are important comes at a cost.

Women use creatine differently from men, survey reveals

10

Sep 2026

Women use creatine differently from men, survey reveals

A cross-sectional survey of 2,094 current or recent creatine users found that women were more concentrated in shorter-duration use groups than men and reported different supplementation goals, information sources, and knowledge patterns. Women were less likely to cite athletic performance and more likely to cite healthy aging as a goal, while researchers cautioned that the survey design cannot explain why these differences exist.

You may not need 10,000 steps if some of them are taken at a faster pace

10

Sep 2026

You may not need 10,000 steps if some of them are taken at a faster pace

A prospective UK Biobank study of 103,684 adults found that higher peak 30-minute stepping cadence was associated with lower all-cause and cardiovascular mortality across several daily step-count levels. The findings indicate that both total daily steps and the intensity of the most active stepping minutes may matter for mortality risk, particularly for people who find higher step totals difficult to achieve.

Aging brain actively shapes biology and progression of tumors

10

Sep 2026

Aging brain actively shapes biology and progression of tumors

Brain tumors develop within an organ that changes substantially with age. A new review in Ageing and Cancer Research & Treatment examines evidence that the aging brain microenvironment may influence brain tumor progression, treatment resistance, and cognitive outcomes.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.